ATE338118T1 - Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon - Google Patents

Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon

Info

Publication number
ATE338118T1
ATE338118T1 AT98959681T AT98959681T ATE338118T1 AT E338118 T1 ATE338118 T1 AT E338118T1 AT 98959681 T AT98959681 T AT 98959681T AT 98959681 T AT98959681 T AT 98959681T AT E338118 T1 ATE338118 T1 AT E338118T1
Authority
AT
Austria
Prior art keywords
apoep1
compositions
apolipoprotein
peptide
immune
Prior art date
Application number
AT98959681T
Other languages
English (en)
Inventor
Bhagirath Singh
Beverley Rider
Original Assignee
Univ Western Ontario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Western Ontario filed Critical Univ Western Ontario
Application granted granted Critical
Publication of ATE338118T1 publication Critical patent/ATE338118T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98959681T 1997-12-12 1998-12-11 Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon ATE338118T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6953197P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
ATE338118T1 true ATE338118T1 (de) 2006-09-15

Family

ID=22089612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959681T ATE338118T1 (de) 1997-12-12 1998-12-11 Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon

Country Status (8)

Country Link
US (1) US6652860B1 (de)
EP (1) EP1036174B1 (de)
AT (1) ATE338118T1 (de)
AU (1) AU1552599A (de)
CA (1) CA2314397C (de)
DE (1) DE69835766T2 (de)
ES (1) ES2276481T3 (de)
WO (1) WO1999031227A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20080194489A1 (en) * 2001-12-21 2008-08-14 Khan Nisar A Treatment of iatrogenic disease
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
JP4910700B2 (ja) * 2004-08-30 2012-04-04 東レ株式会社 分画装置
EP1844033B1 (de) * 2005-01-28 2011-07-27 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur herstellung von isochroman und derivaten davon
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
JP5706818B2 (ja) * 2008-07-01 2015-04-22 コグノッシ， インコーポレイテッド ＡｐｏＥペプチドにより癌を治療する方法
EP2408812B1 (de) 2009-03-17 2015-12-16 CardioVax, LLC Immunmodulatorische Verfahren und Systeme zur Behandlung und/oder Prävention von Atherosklerose sowie zugehörige Proteine, Peptide und Zusammensetzungen
EP2305277A1 (de) * 2009-09-18 2011-04-06 Forskarpatent I Syd AB Verwendung von tolerogenen dendritischen Zellen bei der Behandlung und Vorbeugung von Atherosklerose
AU2010319323B2 (en) 2009-11-14 2015-01-15 Cardiovax, Llc Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
WO2011085110A1 (en) 2010-01-06 2011-07-14 Cognosci, Inc. Apoe peptide dimers and uses thereof
JP2014516913A (ja) 2010-11-12 2014-07-17 シーダース シナイ メディカル センター 高血圧の治療及び／又は予防のための免疫調節方法及びシステム
JP2013544243A (ja) 2010-11-12 2013-12-12 シーダース シナイ メディカル センター 動脈瘤の治療及び／又は予防のための免疫調節方法及びシステム
JP6320382B2 (ja) 2012-08-13 2018-05-09 ザ ロックフェラー ユニヴァーシティ メラノーマの処置および診断
JP2021504315A (ja) 2017-11-21 2021-02-15 ルジェニクス，インコーポレーテッド 多形及びその使用
US11174220B2 (en) 2019-12-13 2021-11-16 Inspirna, Inc. Metal salts and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU587989B2 (en) 1984-10-16 1989-09-07 Mitsubishi Chemical Corporation DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins

Also Published As

Publication number Publication date
WO1999031227A3 (en) 1999-07-29
ES2276481T3 (es) 2007-06-16
CA2314397A1 (en) 1999-06-24
EP1036174B1 (de) 2006-08-30
WO1999031227A2 (en) 1999-06-24
US6652860B1 (en) 2003-11-25
DE69835766D1 (de) 2006-10-12
AU1552599A (en) 1999-07-05
CA2314397C (en) 2010-04-13
EP1036174A2 (de) 2000-09-20
DE69835766T2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
ATE338118T1 (de) Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon
WO1999012968A3 (en) Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
ATE500323T1 (de) Subtilisin-variante
DE69838143D1 (de) Antimikrobielle peptide
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
WO2003096984A3 (en) Drug therapy for celiac sprue
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
BR9708220A (pt) Peptìdios de ligação hla-a2.1 e seus usos
MX9700851A (es) Adenovirus que comprende un gen codificante para la glutation peroxidasa.
WO2001025438A3 (en) Ifn-alpha homologues
IT1212508B (it) Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
MY104909A (en) Peptide compounds.
IL126221A0 (en) Scf analog compositions and methods
WO1998017626A3 (en) Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
ATE352556T1 (de) Zytomodulierende lipophile peptide zur modulation der immunsystemaktivität und hemmung von entzündungen
AU2676801A (en) Xylosyltransferase and isoforms thereof
ES8801316A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
ATE371737T1 (de) Proteaseresistente flint-analoge
AR009840A1 (es) Preparado vacunal para la inmunocastracion revesible de mamiferos
ATE427355T1 (de) Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna
DE60044468D1 (de) Herstellung von sekretierten polypeptiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties